Therefore, the latter in vivo studies suggest that, via the elevated clearance of Aβ or related amyloids, AG fosters the cerebral insulin sensitivity and prevents insulin resistance-associated bioenergetic impairments, thus elevating cognition during AD. This evidence concerns the gene INS and amyloidosis.